Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-23-004427
Filing Date
2023-02-09
Accepted
2023-02-09 16:51:08
Documents
1
Period of Report
2023-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2169
  Complete submission text file 0000899243-23-004427.txt   3546
Mailing Address (135-270) 7TH FLOOR, SOFTFORUM B/D. 545-7 DOGOKDONG GANGNAM, SEOUL M5 135-170
Business Address
Yoo David Jin (Reporting) CIK: 0001458458 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41390 | Film No.: 23607027

Mailing Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004
Business Address 10900 NE 4TH STREET, SUITE 2300 BELLEVUE WA 98004 425-635-7700
Bellevue Life Sciences Acquisition Corp. (Issuer) CIK: 0001840425 (see all company filings)

EIN.: 845052822 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6770 Blank Checks